Diagnostics
Total Trials
7
As Lead Sponsor
0
As Collaborator
Total Enrollment
6,035
NCT03870620
Metastatic Breast Cancer in Austria
Phase: N/A
Role: Collaborator
Start: Jun 15, 2015
Completion: Jun 30, 2025
NCT02967770
Molecularly Tailored Therapy to Standard of Care as Second-Line Therapy in Metastatic Pancreatic Cancer
Phase: Phase 2
Start: Nov 30, 2016
Completion: Aug 30, 2018
NCT03834220
Basket Trial in Solid Tumors Harboring a Fusion of FGFR1, FGFR2 or FGFR3- (FUZE Clinical Trial)
Start: Mar 22, 2019
Completion: Jan 4, 2022
NCT05692466
"Discovering Novel Cancer Treatment Options Using a Comprehensive NGS-based Molecular Testing Panel in the Community Setting (DINOSAur)"
Start: Feb 1, 2023
Completion: Nov 1, 2025
NCT06708715
Stress Reduction After Use of a Haptic Vibrotactile Trigger Technology Patch: Analysis and Assessment
Start: May 5, 2023
Completion: Feb 1, 2025
NCT06430879
Performance Output With Haptics - Evaluating Athlete Response and Unrealized Potential
Start: Jul 10, 2024
Completion: Sep 1, 2024
NCT06505005
Relieving Pain and Improving Sleep: Evaluating Topical Pain Relief and Sleep Patches
Start: Sep 20, 2024
Loading map...